不用本金就能赚钱的方法

来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

现在位置不用本金就能赚钱的方法>技术资料不用本金就能赚钱的方法>行业动态>新品动态>Illumina公司和康圣环球正式宣布战略性合作

Illumina公司和康圣环球正式宣布战略性合作

Illumina2013年5月2日 13:38 点击:2330


 

2013年4月18日,Illumina公司和康圣环球宣布战略合作, Illumina为康圣环球提供TruSightTM 和NuPCRTM 等诊断试剂

Illumina公司(美国纳斯达克编号:ILMN)和康圣环球于今日宣布他们签订了一个战略合作关系,批准康圣环球在自己的实验室实施分子试验,这些试验将运用Illumina的技术,如:TruSightTM content sets、Infinium® Dx CytoSNP-12 assay和NuPCRTM等诊断试剂。此次合作将使康圣环球在全中国超过3300家医院的网络内扩展它高深专业的测试服务。

不用本金就能赚钱的方法“KANGSHENGHUANQIUZAITAGUANGKUODEZHONGGUOWANGLUONEICAIYONGIlluminaDETruSightJISHU, WEIWOMENCHUANGXINDEYEWUNEIRONG,QIGUANGDUHESHENDUTIGONGLEDALIDEXUANCHUAN。”IlluminaZHUANHUAHEKEHUJIYINXUEYEWUBUGAOJIFUZONGCAIHEZONGJINGLIMatt PosardXIANSHENGRUSHISHUO,“XINYIDAIDEPAIXUWULUNZAIFENZIZHENDUANDEFUGAIFANWEIHAISHIJINGQUEXINGSHANGDOURANGWOMENGANSHOUDAOJIDONGRENXINDEFEIYUE。WOMENQIDAIZHEGENGDUODEHEZUOHUOBANGUANXILAIJIXUTUIDONGZHEIZHONGXIANGQIANFAZHANDEQUSHI。”

“KANGSHENGHUANQIUHENXINGFENNENGZAIZHONGGUOTIGONGJIYUIlluminaJISHUDEFUWU,BAOKUOTruSight content setsZHENDUANSHIJIZAINEI,”KANGSHENGHUANQIUDECHUANGSHIRENHEZHIXINGZONGCAIHUANGBOSHISHUO,“YUNYONGIlluminaDEJISHUJIANGSHIWOMENNENGJIKEHUTIGONGZHILIANGZUIGAO、ZUIZHUANYEDEZHENDUAN。”

关于康圣环球
不用本金就能赚钱的方法 康圣环球是一家在北京、上海和武汉都拥有实验室的集团公司,它为中国各省市的医院和医务人员提供及其专业的诊断测试服务。康圣环球是中国首家也是最大的专业诊断测试企业,为超过3300家中国医院,其中包括930家三甲医院(中国最高医院等级)提供实验室测试服务。康圣环球已成为中国医生的首选合作伙伴,在许多医学专业上,包括血液学、肿瘤学、传染病和医学遗传学方面为医生提供先进的诊断服务。


关于Illumina
Illumina (公司网址:www.illumina.com)是一家对生命科学工具和基因变化及功能分析的集成系统进行研发、制造和市场宣传的领导企业,我们为基因分型、拷贝数变异分析、甲基化研究、基因表达谱、DNA, RNA和蛋白质的低复用分析提供创新的排序和基于序列的解决方案,我们还为客户在基因组学和诊断学方面提供促进发展工具和服务。我们的技术和产品加快了基因分析研究及其运用,为分子医学及其最终转化为医疗运用铺平了道路。


Illumina公司行业地位
Illumina公司:DNA的未来
作者: Richard McGill Murphy 时间: 2012年12月13日 来源: 财富中文网据晨星公司分析师查理·米勒统计,快速增长的基因序列市场价值12亿美元,Illumina公司以60%的市场份额独占鳌头。美国增长最快公司排名:第23位
公司总部:圣迭戈
员工人数:2,200
经营业务:为医疗研究人员提供基因分析工具



Illumina and Kindstar Global Announce Strategic Collaboration to Facilitate Clinical Adoption of Illumina Technologies in Asia

SAN DIEGO & WUHAN, China--(BUSINESS WIRE)--Apr. 18, 2013-- Illumina, Inc. (NASDAQ: ILMN) and Kindstar Global (Kindstar) today announced they are entering into a strategic collaboration whereby Kindstar will validate and implement molecular assays in their laboratories, leveraging Illumina's TruSightTM content sets, Infinium® Dx CytoSNP-12 assay and NuPCRTM reagents. The collaboration will enable Kindstar to expand its esoteric and specialty testing services offerings within its network of more than 3,300 hospitals across China.

"Kindstar's adoption of Illumina's TruSight technology across its extensive network in China speaks to the breadth and depth of content in this innovative portfolio," said  Matt Posard, Senior Vice President and General Manager of Illumina's Translational and Consumer Genomics business. "Next-generation sequencing is enabling a dramatic improvement in both coverage and accuracy for molecular diagnostics, and we look forward to additional partnerships that continue to drive this improvement forward."

"Kindstar is excited to offer services in China based on Illumina's products including the TruSight content sets," said Dr.  Shiang Huang, Founder and CEO of Kindstar. "Leveraging Illumina's technology will enable us to offer the highest quality and most specialized diagnostics."

About Illumina

Illumina () is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.

About Kindstar Global

Kindstar Global, with laboratory facilities in Beijing, Shanghai and Wuhan, provides esoteric diagnostic testing services to hospitals and physicians in every province of China. Kindstar is the first and largest esoteric diagnostic testing business in China, providing laboratory testing services to over 3,300 Chinese hospitals, including 930 tertiary hospitals (classification for largest leading hospitals). Kindstar is becoming the partner of choice to physicians in China for advanced diagnostics in many medical specialties including hematology, oncology, infectious diseases and medical genetics.

Forward-Looking Statements

This release may contain forward looking statements that involve risks and uncertainties. Important factors that could cause actual results to differ materially from those in any forward-looking statements are detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We do not intend to update any forward-looking statements after the date of this release.

Source: Illumina, Inc.

Illumina Inc.
Investors:

Rebecca Chambers
858-255-5243
rchambers@illumina.com
or
Media:
Jennifer Temple
858-882-6822
pr@illumina.com

(来源: Illumina )


全年征稿 / 资讯合作

联系邮箱:kefu@strauss-usa.com不用本金就能赚钱的方法

不用本金就能赚钱的方法 BANQUANYUMIANZESHENGMING

  • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://strauss-usa.com,违反者本网将追究相关法律责任。
  • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
  • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。


湖南快乐十分 湖南快乐十分 福建快3走势图0 福建快3走势图 河南快3走势图 河南快3走势图 广东11选5开奖结果 福建11选5走势图